Fuso Pharmaceutical Industries,Ltd. (4538.T)
JPY 2234.0
(0.0%)
JPY 2234.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.96 Billion JPY | -10.92% |
| 2022 | 2.2 Billion JPY | 14.66% |
| 2021 | 1.92 Billion JPY | -18.16% |
| 2020 | 2.35 Billion JPY | 132.77% |
| 2019 | 1.01 Billion JPY | -19.9% |
| 2018 | 1.26 Billion JPY | 58.02% |
| 2017 | 798 Million JPY | 21.65% |
| 2016 | 656 Million JPY | 121.62% |
| 2015 | 296 Million JPY | -62.81% |
| 2014 | 796 Million JPY | -71.54% |
| 2013 | 2.79 Billion JPY | -26.7% |
| 2012 | 3.81 Billion JPY | 695.0% |
| 2011 | 480 Million JPY | -77.87% |
| 2010 | 2.16 Billion JPY | 368.47% |
| 2009 | 463 Million JPY | 56.42% |
| 2008 | 296 Million JPY | 167.43% |
| 2007 | -439 Million JPY | -172.68% |
| 2006 | 604 Million JPY | -29.85% |
| 2005 | 861 Million JPY | -37.88% |
| 2004 | 1.38 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.15 Billion JPY | 843.44% |
| 2023 Q2 | 510 Million JPY | -13.41% |
| 2023 Q1 | 589 Million JPY | 144.4% |
| 2023 Q4 | 122 Million JPY | -83.58% |
| 2023 FY | 1.96 Billion JPY | -10.92% |
| 2023 Q3 | 743 Million JPY | 45.69% |
| 2022 Q2 | 663 Million JPY | 6.59% |
| 2022 Q4 | 241 Million JPY | -64.56% |
| 2022 Q1 | 622 Million JPY | 10466.67% |
| 2022 Q3 | 680 Million JPY | 2.56% |
| 2022 FY | 2.2 Billion JPY | 14.66% |
| 2021 Q4 | -6 Million JPY | -100.89% |
| 2021 FY | 1.92 Billion JPY | -18.16% |
| 2021 Q3 | 677 Million JPY | 5.62% |
| 2021 Q1 | 612 Million JPY | 3925.0% |
| 2021 Q2 | 641 Million JPY | 4.74% |
| 2020 Q4 | -16 Million JPY | -102.42% |
| 2020 Q1 | 967 Million JPY | 19240.0% |
| 2020 Q2 | 738 Million JPY | -23.68% |
| 2020 FY | 2.35 Billion JPY | 132.77% |
| 2020 Q3 | 662 Million JPY | -10.3% |
| 2019 FY | 1.01 Billion JPY | -19.9% |
| 2019 Q4 | 5 Million JPY | -98.82% |
| 2019 Q2 | 99 Million JPY | -79.42% |
| 2019 Q1 | 481 Million JPY | 2431.58% |
| 2019 Q3 | 425 Million JPY | 329.29% |
| 2018 Q3 | 588 Million JPY | 48.48% |
| 2018 FY | 1.26 Billion JPY | 58.02% |
| 2018 Q1 | 258 Million JPY | 1884.62% |
| 2018 Q2 | 396 Million JPY | 53.49% |
| 2018 Q4 | 19 Million JPY | -96.77% |
| 2017 Q1 | 145 Million JPY | 259.34% |
| 2017 FY | 798 Million JPY | 21.65% |
| 2017 Q3 | 459 Million JPY | 153.59% |
| 2017 Q2 | 181 Million JPY | 24.83% |
| 2017 Q4 | 13 Million JPY | -97.17% |
| 2016 Q1 | 275 Million JPY | 203.38% |
| 2016 FY | 656 Million JPY | 121.62% |
| 2016 Q4 | -91 Million JPY | -129.17% |
| 2016 Q3 | 312 Million JPY | 95.0% |
| 2016 Q2 | 160 Million JPY | -41.82% |
| 2015 FY | 296 Million JPY | -62.81% |
| 2015 Q4 | -266 Million JPY | -170.18% |
| 2015 Q3 | 379 Million JPY | 858.0% |
| 2015 Q2 | -50 Million JPY | -121.46% |
| 2015 Q1 | 233 Million JPY | 1394.44% |
| 2014 Q3 | 472 Million JPY | 140.82% |
| 2014 Q4 | -18 Million JPY | -103.81% |
| 2014 FY | 796 Million JPY | -71.54% |
| 2014 Q1 | 146 Million JPY | -12.05% |
| 2014 Q2 | 196 Million JPY | 34.25% |
| 2013 Q2 | 718 Million JPY | -20.31% |
| 2013 Q4 | 166 Million JPY | -83.6% |
| 2013 FY | 2.79 Billion JPY | -26.7% |
| 2013 Q1 | 901 Million JPY | 85.01% |
| 2013 Q3 | 1.01 Billion JPY | 40.95% |
| 2012 Q3 | 1.27 Billion JPY | 30.49% |
| 2012 Q4 | 487 Million JPY | -61.68% |
| 2012 Q1 | 1.08 Billion JPY | 794.87% |
| 2012 FY | 3.81 Billion JPY | 695.0% |
| 2012 Q2 | 974 Million JPY | -10.15% |
| 2011 Q1 | -140 Million JPY | -159.32% |
| 2011 Q2 | 323 Million JPY | 330.71% |
| 2011 Q3 | 453 Million JPY | 40.25% |
| 2011 Q4 | -156 Million JPY | -134.44% |
| 2011 FY | 480 Million JPY | -77.87% |
| 2010 Q3 | 928 Million JPY | 19.74% |
| 2010 Q2 | 775 Million JPY | 238.43% |
| 2010 FY | 2.16 Billion JPY | 368.47% |
| 2010 Q4 | 236 Million JPY | -74.57% |
| 2010 Q1 | 229 Million JPY | 324.07% |
| 2009 Q1 | 89 Million JPY | 116.42% |
| 2009 Q4 | 54 Million JPY | -78.99% |
| 2009 Q3 | 257 Million JPY | 314.52% |
| 2009 Q2 | 62 Million JPY | -30.34% |
| 2009 FY | 463 Million JPY | 56.42% |
| 2008 Q2 | 166 Million JPY | 0.0% |
| 2008 FY | 296 Million JPY | 167.43% |
| 2008 Q4 | -542 Million JPY | -211.07% |
| 2008 Q3 | 488 Million JPY | 193.98% |
| 2007 FY | -439 Million JPY | -172.68% |
| 2006 FY | 604 Million JPY | -29.85% |
| 2005 FY | 861 Million JPY | -37.88% |
| 2004 FY | 1.38 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | 61.588% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 99.083% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 100.554% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 98.855% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 1104.547% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 93.742% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 79.355% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 96.323% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -174.302% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 85.084% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 66.155% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 497.571% |
| Tsumura & Co. | 20.01 Billion JPY | 90.189% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | 51.108% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | 61.001% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 88.871% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | 49.093% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 79.787% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 67.337% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 163.787% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | 49.563% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 341.971% |
| MedRx Co., Ltd | -933 Million JPY | 310.504% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | 61.879% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 272.432% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 182.869% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 69.785% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 89.601% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 381.602% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 89.84% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | 55.184% |